tiprankstipranks
Advertisement
Advertisement

LUCD Stock Latest News

Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating
RatingsLucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating
3d ago
LUCD
Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant
PremiumThe Fly
Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant
10d ago
LUCD
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
PremiumCompany Announcements
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
21d ago
LUCD
Is LUCD a Buy, Before Earnings?
PremiumPre-Earnings
Is LUCD a Buy, Before Earnings?
22d ago
LUCD
Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract
PremiumCompany Announcements
Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract
24d ago
8K
LUCD
Lucid Diagnostics reports Q4 adjusted EPS (10c) vs. (19c) last year
PremiumThe FlyLucid Diagnostics reports Q4 adjusted EPS (10c) vs. (19c) last year
24d ago
LUCD
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
3M ago
AMD
DIA
Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?
Premium
Market News
Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?
3M ago
LUCD
PAVM
Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard
PremiumThe Fly
Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard
3M ago
LUCD
PAVM
Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant
PremiumThe Fly
Lucid Diagnostics price target raised to $8.25 from $8 at Ascendiant
4M ago
LUCD
Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study
PremiumThe Fly
Lucid Diagnostics’ esophageal precancer detection tools show efficacy in study
4M ago
LUCD
PAVM
Lucid Diagnostics files $175M mixed securities shelf
PremiumThe Fly
Lucid Diagnostics files $175M mixed securities shelf
4M ago
LUCD
Lucid Diagnostics: Buy Rating Backed by Strong Growth, Financial Stability, and Strategic Expansion
PremiumRatingsLucid Diagnostics: Buy Rating Backed by Strong Growth, Financial Stability, and Strategic Expansion
5M ago
LUCD
Lucid Diagnostics: Positive Indicators and Medicare Reimbursement Potential Support Buy Rating
Premium
Ratings
Lucid Diagnostics: Positive Indicators and Medicare Reimbursement Potential Support Buy Rating
5M ago
LUCD
Positive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management
Premium
Ratings
Positive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management
5M ago
LUCD
Lucid Diagnostics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Lucid Diagnostics Reports Q3 2025 Financial Results
5M ago
LUCD
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges
PremiumCompany Announcements
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges
5M ago
LUCD
Lucid Diagnostics Gains Medicare Support for EsoGuard
PremiumCompany Announcements
Lucid Diagnostics Gains Medicare Support for EsoGuard
5M ago
8K
LUCD
Lucid Diagnostics reports Q3 EPS (10c), consensus (9c)
PremiumThe Fly
Lucid Diagnostics reports Q3 EPS (10c), consensus (9c)
5M ago
LUCD
Lucid Diagnostics Appoints John R. Palumbo to Board
PremiumCompany AnnouncementsLucid Diagnostics Appoints John R. Palumbo to Board
7M ago
8K
LUCD
Lucid Diagnostics Completes Public Offering for $26.9 Million
Premium
Company Announcements
Lucid Diagnostics Completes Public Offering for $26.9 Million
7M ago
8K
LUCD
Lucid Diagnostics Announces Public Stock Offering
Premium
Company Announcements
Lucid Diagnostics Announces Public Stock Offering
7M ago
8K
LUCD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >